Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

Lexaria Bioscience (LEXX)

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center

pharmaceutical investing
Lexaria Bioscience (LEXX)

Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell's Cell-Based ‘Melanoma’ Enters the Skin Cancer Vaccine Conversation

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Receives USD$2.6 Million Tax Rebate Payment

biotech investing
Lexaria Bioscience (LEXX)

DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2

biotech investing
Lexaria Bioscience (LEXX)

DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+

pharmaceutical investing
Lexaria Bioscience (LEXX)

Lexaria Enters a Material Transfer Agreement With PegBio

biotech investing
Solvonis Therapeutics (None)

SVN-015 Advances into Further NIDA-Funded Studies Following Encouraging Initial Screening

BriaCell Therapeutics (BCT:CC)

BriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT

pharmaceutical investing

Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa

Lexaria Bioscience (LEXX)

Lexaria Updates Business Development

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Updates Business Development

biotech investing
Lexaria Bioscience (LEXX)

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT

pharmaceutical investing

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES